Hypopharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials
• Forums

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Conditions:   Head and Neck Carcinoma of Unknown Primary;   Locally Advanced Head and Neck Squamous Cell Carcinoma;   Locally Advanced Hypopharyngeal Squamous Cell Carcinoma;   Locally Advanced Laryngeal Squamous Cell Carcinoma;   Locally Advanced Nasopharyngeal Squamous Cell Carcinoma;   Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions:   Drug: Tolinapant;   Radiation: Radiation Therapy Sponsors:   Emory University;   Astex Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Conditions:   Head and Neck Carcinoma of Unknown Primary;   Locally Advanced Head and Neck Squamous Cell Carcinoma;   Locally Advanced Hypopharyngeal Squamous Cell Carcinoma;   Locally Advanced Laryngeal Squamous Cell Carcinoma;   Locally Advanced Nasopharyngeal Squamous Cell Carcinoma;   Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions:   Drug: Tolinapant;   Radiation: Radiation Therapy Sponsors:   Emory University;   Astex Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials